News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) Skyrockets as Cancer Drug is Highly Effective in Trial, Shares Up +44.72% @ Market Close (November 7, 2013)



11/7/2013 8:30:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Geron Corp said 22 percent of patients treated by its experimental blood cancer drug in a clinical trial were free of the disease, and its shares more than doubled in value in early trading. The company also said that one patient, of the first 18 patients enrolled in the trial, showed a partial remission to the drug, known as imetelstat.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES